195 related articles for article (PubMed ID: 32143736)
1. Combinative evaluation of primary tumor and lymph nodes to predict pelvic lymphatic metastasis in cervical cancer: an integrated PET-IVIM MRI study.
Xu C; Li X; Shi Y; Wang B; Sun H
Cancer Imaging; 2020 Mar; 20(1):21. PubMed ID: 32143736
[TBL] [Abstract][Full Text] [Related]
2. Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study.
Xu C; Du S; Zhang S; Wang B; Dong C; Sun H
Eur Radiol; 2020 May; 30(5):2483-2492. PubMed ID: 32040728
[TBL] [Abstract][Full Text] [Related]
3. Value of integrated PET-IVIM MRI in predicting lymphovascular space invasion in cervical cancer without lymphatic metastasis.
Xu C; Yu Y; Li X; Sun H
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2990-3000. PubMed ID: 33506309
[TBL] [Abstract][Full Text] [Related]
4. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
Li K; Sun H; Guo Q
Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
Gao S; Du S; Lu Z; Xin J; Gao S; Sun H
Eur Radiol; 2020 Feb; 30(2):1191-1201. PubMed ID: 31493211
[TBL] [Abstract][Full Text] [Related]
6. Relationship between
Du S; Sun H; Gao S; Xin J; Lu Z; Chen Z; Pan S; Guo Q
Clin Radiol; 2019 Mar; 74(3):178-186. PubMed ID: 30545566
[TBL] [Abstract][Full Text] [Related]
7. Value of [
Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of Predicting Pelvic Lymph Node Metastasis Based on IVIM-DWI and Texture Parameters of the Primary Lesion and Lymph Nodes in Patients with Cervical Cancer.
Zhang Y; Zhang KY; Jia HD; Fang X; Lin TT; Wei C; Qian LT; Dong JN
Acad Radiol; 2022 Jul; 29(7):1048-1057. PubMed ID: 34654623
[TBL] [Abstract][Full Text] [Related]
9. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
Son SH; Jeong SY; Chong GO; Lee YH; Park SH; Lee CH; Hong CM; Jeong JH; Lee SW; Ahn BC; Lee J
Clin Nucl Med; 2018 Sep; 43(9):e296-e303. PubMed ID: 30036243
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT
Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970
[TBL] [Abstract][Full Text] [Related]
12. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.
Kim SK; Choi HJ; Park SY; Lee HY; Seo SS; Yoo CW; Jung DC; Kang S; Cho KS
Eur J Cancer; 2009 Aug; 45(12):2103-9. PubMed ID: 19403303
[TBL] [Abstract][Full Text] [Related]
13. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
Park SY; Yoon JK; Park KJ; Lee SJ
Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918
[TBL] [Abstract][Full Text] [Related]
14. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
15. Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
Shim SH; Kim DY; Lee SJ; Kim SN; Kang SB; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2017 Jan; 144(1):40-45. PubMed ID: 27855989
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
Chong GO; Jeong SY; Park SH; Lee YH; Lee SW; Hong DG; Kim JC; Lee YS; Cho YL
PLoS One; 2015; 10(9):e0137743. PubMed ID: 26368542
[TBL] [Abstract][Full Text] [Related]
17. Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer.
Chung HH; Kang KW; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Chung JK; Kang SB
Am J Obstet Gynecol; 2010 Aug; 203(2):156.e1-5. PubMed ID: 20435285
[TBL] [Abstract][Full Text] [Related]
18. Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography.
Wright JD; Dehdashti F; Herzog TJ; Mutch DG; Huettner PC; Rader JS; Gibb RK; Powell MA; Gao F; Siegel BA; Grigsby PW
Cancer; 2005 Dec; 104(11):2484-91. PubMed ID: 16270319
[TBL] [Abstract][Full Text] [Related]
19. Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy.
Chung HH; Park NH; Kim JW; Song YS; Chung JK; Kang SB
Gynecol Obstet Invest; 2009; 67(1):61-6. PubMed ID: 18843187
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer.
Crivellaro C; Signorelli M; Guerra L; De Ponti E; Buda A; Dolci C; Pirovano C; Todde S; Fruscio R; Messa C
Gynecol Oncol; 2012 Oct; 127(1):131-5. PubMed ID: 22772064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
